91 results
Page 2 of 5
8-K
EX-99.2
4galxe
16 May 22
PhaseBio Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business Highlights
12:00am
8-K
EX-99.2
64nlildi73xyvuenn
24 Mar 22
PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
4:12pm
8-K
EX-99.1
rmyg9bsbqzs03aunlzq
24 Mar 22
PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
4:12pm
8-K
EX-99.2
aee7d1 7bh2t07n38
15 Nov 21
Regulation FD Disclosure
11:32am
8-K
EX-99.2
m2e 0ldiys
10 Nov 21
PhaseBio Reports Third-Quarter 2021 Financial Results and Recent Business Highlights
4:35pm
8-K
EX-99.1
1652tvc6uh4xrsxnc
10 Nov 21
PhaseBio Reports Third-Quarter 2021 Financial Results and Recent Business Highlights
4:35pm
8-K
EX-99.2
ygmp1aoj29c0qvp
12 Aug 21
PhaseBio Reports Second-Quarter 2021 Financial Results and Recent Business Highlights
10:11am
8-K
EX-99.1
2n1nfu 1i5p34a5h9la4
12 Aug 21
PhaseBio Reports Second-Quarter 2021 Financial Results and Recent Business Highlights
10:11am
8-K
qwohpjv2wp
17 Jun 21
PhaseBio Announces European Licensing Agreement with Alfasigma S.p.A for Commercialization of Bentracimab
8:13am
8-K
EX-99.1
ale6f1skk5f54ka48yo1
13 May 21
PhaseBio Reports First-Quarter 2021 Financial Results and Recent Business Highlights
4:06pm
8-K
EX-99.2
50p8kl3z 0r
13 May 21
PhaseBio Reports First-Quarter 2021 Financial Results and Recent Business Highlights
4:06pm
424B5
252fgfyvqf9qb
19 Mar 21
Prospectus supplement for primary offering
4:04pm